Arrowgrass Capital Partners (US)’s Biogen BIIB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-67,000	Closed	-$21.3M	–	187
2017 Q4	$21.3M	Buy	67,000 +65,938	+6,209%	+$21.2M	0.5%	118
2017 Q3	$33.3M	Hold	1,062	–	–	0.55%	97
2017 Q2	$28.8M	Buy	1,062 +912	+608%	+$241K	0.48%	120
2017 Q1	$4.1M	Sell	150 -480	-76%	-$136K	0.1%	350
2016 Q4	$17.9M	Buy	630 +39	+7%	+$11.6K	0.48%	111
2016 Q3	$18.5M	Sell	591 -312	-35%	-$92.4K	0.45%	89
2016 Q2	$21.8M	Buy	903 +80	+10%	+$21.1K	0.49%	69
2016 Q1	$21.4M	Buy	823 +473	+135%	+$125K	0.45%	69
2015 Q4	$10.7M	Buy	+350	New	+$101K	0.21%	101
2015 Q3	–	Sell	-210	Closed	-$8.48M	–	461
2015 Q2	$8.48M	Buy	210 +99	+89%	+$39.7K	0.24%	152
2015 Q1	$4.69M	Sell	111 -34,689	-100%	-$13.7M	0.14%	155
2014 Q4	$11.8M	Buy	+34,800	New	+$11.3M	0.32%	69
2014 Q2	–	Sell	-1,700	Closed	-$520K	–	235
2014 Q1	$520K	Buy	+1,700	New	+$540K	0.02%	151